Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof

Details for Australian Patent Application No. 2010249244 (hide)

Owner Abbott GmbH & Co. KG

Inventors Breitenbach, Jorg; Rosenberg, Jorg; Marsh, Kennan C.; Degenhardt, Matthias; Reiland, Tom L.

Agent Watermark

Pub. Number AU-A-2010249244

Parent 2003290060

Filing date 13 December 2010

Wipo publication date 6 January 2011

International Classifications

A61K 31/216 (2006.01)

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/192 (2006.01)

A61K 31/205 (2006.01)

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

Event Publications

23 December 2010 Complete Application Filed

6 January 2011 Application Open to Public Inspection

  Published as AU-A-2010249244

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010249245-High precision delay system

2010249243-A smart card, biometric sensor and smart card reader, and method of use for expenditure and gambling control